These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7405173)

  • 21. [Clinical significance of histocompatibility antigens of the HLA system in the development of ischemic heart disease].
    Timoshenko OL; Burka NI
    Vrach Delo; 1988 Nov; (11):38-40. PubMed ID: 3238975
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood pressure at health screening as a predictor of coronary heart disease in Kyoto.
    Sasaki S; Nakamura K; Uchida A; Fujita H; Itoh H; Nakata T; Takeda K; Nakagawa M
    J Cardiovasc Risk; 1996 Feb; 3(1):77-82. PubMed ID: 8783034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness of ambulatory treatment and methods of prophylaxis in coronary arteriosclerosis].
    Koshkina KP
    Vrach Delo; 1973 Mar; 3():46-8. PubMed ID: 4733030
    [No Abstract]   [Full Text] [Related]  

  • 24. [The role of physical activity in the prevention and treatment of ischemic heart disease].
    Denolin H
    Ann Cardiol Angeiol (Paris); 1981; 30(2):103-8. PubMed ID: 7259041
    [No Abstract]   [Full Text] [Related]  

  • 25. [Registry of pulmonary tuberculosis patients over 50 and their social conditions and life style characteristics].
    Fedoseev GS
    Probl Tuberk; 1982 Nov; (11):8-11. PubMed ID: 7156113
    [No Abstract]   [Full Text] [Related]  

  • 26. Collaboration in coronary heart disease prevention.
    Jones A; Sibbons M; Hunt J; Patterson J; Sprately J; Sykes A
    Health Visit; 1993 Jul; 66(7):257-9. PubMed ID: 8365896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the value of mass screening for coronary risks.
    Leaman DM; Crawshaw SL; Zelis RF
    Pa Med; 1981 Feb; 84(2):29-31. PubMed ID: 6785708
    [No Abstract]   [Full Text] [Related]  

  • 28. Screening and treatment of hypercholesterolemia for prevention of coronary heart disease.
    Wang YR; Alexander GC; Meltzer DO
    Manag Care Interface; 2006 Jan; 19(1):25-9. PubMed ID: 16453992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polish experiment in the prevention of ischemic heart disease. V. Prevalence of coronary disease risk in a male population in Warsaw industrial plants].
    Charzewska J; Rywik S; Chabros E; Wagrowska H; Chotkowska E
    Kardiol Pol; 1980; 23(3):185-93. PubMed ID: 7373969
    [No Abstract]   [Full Text] [Related]  

  • 30. [Functional status of the cardiovascular system in persons with risk factors for ischemic heart disease].
    Gembitskiĭ EV; Kondrakov VM
    Sov Med; 1985; (8):93-6. PubMed ID: 4059995
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of ischemic heart diseases in primary health care. Distribution of risk factors in a risk group].
    Saelan H; Krasnik A
    Ugeskr Laeger; 1979 Sep; 141(39):2695-700. PubMed ID: 531958
    [No Abstract]   [Full Text] [Related]  

  • 32. From epidemiology to prevention.
    Rose G
    Verh Dtsch Ges Kreislaufforsch; 1975; 41():30-7. PubMed ID: 1231331
    [No Abstract]   [Full Text] [Related]  

  • 33. [Organization of the detection and treatment of ocular pathology in preschool children under the annual outpatient care in Moscow].
    Kovalevskiĭ EI; Korol'chuk AB
    Oftalmol Zh; 1986; (1):1-5. PubMed ID: 3703437
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of ischemic heart disease among the population].
    Oleĭnikov SP; Shishova AM; Balavadze MB; Zyriaeva LA
    Vestn Akad Med Nauk SSSR; 1981; (5):81-3. PubMed ID: 7281961
    [No Abstract]   [Full Text] [Related]  

  • 35. [Detection of early stages of ischemic heart disease in a medical district].
    Sello LN; Edigarova IS
    Vrach Delo; 1979 Jan; (1):24-6. PubMed ID: 154776
    [No Abstract]   [Full Text] [Related]  

  • 36. [Coronary risk factors related to ergometric and radiographic changes, September 1992 to May 1993].
    Pereira García AB; Inufia Suárez R; Prado MI; Rodríguez S; de los Santos N; Dueñas Fernández R
    Rev Cubana Enferm; 1995; 11(2):87-94. PubMed ID: 8715258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Attitude to health problems of persons refusing to participate in prophylactic examinations].
    Goshtautas AA
    Ter Arkh; 1983; 55(1):61-4. PubMed ID: 6836529
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of risk factors for coronary heart disease among attenders and non-attenders at a screening programme.
    Jones A; Cronin PA; Bowen M
    Br J Gen Pract; 1993 Sep; 43(374):375-7. PubMed ID: 8251234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polish experiment with regard to coronary disease prevention. IV. Incidence of ischemic heart disease among male population aged 40-59 from the Warsaw industrial plants participating in the experiment].
    Rywik S; Kuźmińska A; Charzewska J; Chabros E; Wagrowska H; Przestalska-Malkin H
    Kardiol Pol; 1980; 23(1):73-81. PubMed ID: 7366075
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of ischemic heart disease].
    Spácil J
    Cas Lek Cesk; 1984 Jun; 123(25):776-9. PubMed ID: 6467326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.